Fig. 3From: Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancerHRs and ORs for the 10-year signature genes in TransATAC and POLAR, respectively. POLAR Molecular Predictors Of early versus LAte Recurrence in ER-positive breast cancer, ATACÂ Arimidex, Tamoxifen, Alone or in CombinationBack to article page